It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An oxalate-degrading bacterium in the gut microbiota absorbs food-derived oxalate to use this as a carbon and energy source, thereby reducing the risk of kidney stone formation in host animals. The bacterial oxalate transporter OxlT selectively uptakes oxalate from the gut to bacterial cells with a strict discrimination from other nutrient carboxylates. Here, we present crystal structures of oxalate-bound and ligand-free OxlT in two distinct conformations, occluded and outward-facing states. The ligand-binding pocket contains basic residues that form salt bridges with oxalate while preventing the conformational switch to the occluded state without an acidic substrate. The occluded pocket can accommodate oxalate but not larger dicarboxylates, such as metabolic intermediates. The permeation pathways from the pocket are completely blocked by extensive interdomain interactions, which can be opened solely by a flip of a single side chain neighbouring the substrate. This study shows the structural basis underlying metabolic interactions enabling favourable symbiosis.
In our gut, oxalate-degrading bacteria absorb oxalate, a causative substance for kidney stone formation, and reduce our health risk. In this work, the authors report the structure of the oxalate transporter responsible for this process and how the protein works.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details












1 National Institutes of Natural Sciences, Research Center for Computational Science, Institute for Molecular Science, Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732)
2 Kyoto University, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
3 Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472)
4 RIKEN SPring-8 Center, Sayo, Japan (GRID:grid.472717.0)
5 Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472); Okayama University, School of Pharmaceutical Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472)
6 Okayama University, School of Pharmaceutical Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472)
7 Okayama University, Graduate School of Environmental and Life Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472)
8 The University of Tokyo, Research Center for Advanced Science and Technology, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
9 Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472); RIKEN SPring-8 Center, Sayo, Japan (GRID:grid.472717.0); Okayama University, School of Pharmaceutical Sciences, Okayama, Japan (GRID:grid.261356.5) (ISNI:0000 0001 1302 4472)